社论：特刊“干细胞生物学与癌症”
Editorial: Special Issue "Stem Cell Biology and Cancer".
机构信息
Institute for Biomedical Research of Salamanca (IBSAL), Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain.
出版信息
Int J Mol Sci. 2023 Jul 16;24(14):11533. doi: 10.3390/ijms241411533.
Abstract
Cancer stem cells (CSCs) are now well-established as key players in tumor initiation, progression, and therapy resistance [...].
摘要
癌症干细胞（CSCs）现在已经被充分证实为肿瘤起始、进展和治疗抵抗的关键因素[... ]。
相似文献
1
Editorial: Special Issue "Stem Cell Biology and Cancer".社论：特刊“干细胞生物学与癌症”
Int J Mol Sci. 2023 Jul 16;24(14):11533. doi: 10.3390/ijms241411533.
2
The origin of cancer stem cells.癌症干细胞的起源。
Front Biosci (Schol Ed). 2012 Jan 1;4(3):819-30. doi: 10.2741/s302.
3
Cancer stem cells: a new framework for the design of tumor therapies.癌症干细胞：肿瘤治疗设计的新框架。
J Mol Med (Berl). 2011 Feb;89(2):95-107. doi: 10.1007/s00109-010-0685-3. Epub 2010 Oct 2.
4
Cancer stem cells and resistance to chemo and radio therapy.癌症干细胞与化疗和放疗耐药性
Front Biosci (Elite Ed). 2012 Jan 1;4(6):2142-9. doi: 10.2741/531.
5
The clinical and therapeutic implications of cancer stem cell biology.癌症干细胞生物学的临床和治疗意义。
Expert Rev Anticancer Ther. 2011 Jul;11(7):1131-43. doi: 10.1586/era.11.82.
6
Cancer stem cells and angiogenesis.癌症干细胞与血管生成。
Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz.
7
Recurrence cancer stem cells--made by cell fusion?复发性癌症干细胞——由细胞融合产生？
Med Hypotheses. 2009 Oct;73(4):542-7. doi: 10.1016/j.mehy.2009.05.044. Epub 2009 Jun 28.
8
Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.肿瘤干细胞：通往治疗抵抗之路及克服抵抗策略。
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165339. doi: 10.1016/j.bbadis.2018.11.015. Epub 2018 Nov 24.
9
Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study.癌症干细胞、生态位和 EGFR 决定肿瘤发展和治疗反应：一项生物计算模拟研究。
J Theor Biol. 2011 Jan 21;269(1):138-49. doi: 10.1016/j.jtbi.2010.10.016. Epub 2010 Oct 20.
10
Cancer Stem Cells: Root of the Evil.癌症干细胞：万恶之源。
Crit Rev Oncog. 2019;24(1):69-87. doi: 10.1615/CritRevOncog.2019029512.
本文引用的文献
1
Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells.培维酮司他抑制 SOX2 表达和球体形成，但也驱动亚砷酸盐转化的尿路上皮细胞中终末分化标志物的诱导和凋亡。
Int J Mol Sci. 2023 May 23;24(11):9149. doi: 10.3390/ijms24119149.
2
Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells.靶向维甲酸途径根除癌症干细胞。
Int J Mol Sci. 2023 Jan 25;24(3):2373. doi: 10.3390/ijms24032373.
3
Hematopoietic and Chronic Myeloid Leukemia Stem Cells: Multi-Stability versus Lineage Restriction.造血和慢性髓性白血病干细胞：多稳定性与谱系限制。
Int J Mol Sci. 2022 Nov 5;23(21):13570. doi: 10.3390/ijms232113570.
4
NSD2 as a Promising Target in Hematological Disorders.NSD2 作为血液系统疾病的一个有前途的靶点。
Int J Mol Sci. 2022 Sep 21;23(19):11075. doi: 10.3390/ijms231911075.
5
Childhood B-Cell Preleukemia Mouse Modeling.儿童 B 细胞前白血病小鼠模型。
Int J Mol Sci. 2022 Jul 8;23(14):7562. doi: 10.3390/ijms23147562.
6
Stem Cell Models for Cancer Therapy.癌症治疗的干细胞模型。
Int J Mol Sci. 2022 Jun 24;23(13):7055. doi: 10.3390/ijms23137055.
7
The Social Norm of Hematopoietic Stem Cells and Dysregulation in Leukemia.造血干细胞的社会规范与白血病的失调。
Int J Mol Sci. 2022 May 3;23(9):5063. doi: 10.3390/ijms23095063.
8
Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.胶质母细胞瘤干细胞——抗癌之战中的有用工具。
Int J Mol Sci. 2022 Apr 21;23(9):4602. doi: 10.3390/ijms23094602.
Zotero 插件